This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignees: Yonsung Fine Chemical Co., Ltd., Yonsung Fine Chemical Co., Ltd., Ys Life Science Co. Ltd.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yongin-si, KR (2020)
- Suwon-si, KR (2020 - 2022)
Company Filing History:
Years Active: 2020-2026
Title: Hyun Ik Shin: Innovator in Ophthalmic Treatments
Introduction
Hyun Ik Shin is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. With a total of 5 patents to his name, Shin's work reflects a commitment to advancing medical treatments.
Latest Patents
One of his latest patents is an ophthalmic composition for glaucoma treatment. This eye drop composition includes a prostaglandin analogue, a thickening agent, and a solubilizing agent, wherein the thickening agent is carboxymethylcellulose or a salt thereof, and the solubilizing agent is tyloxapol. Another significant patent is a method for preparing latanoprostene bunod and an intermediate therefor. This invention relates to a process that allows for the efficient and cost-effective preparation of latanoprostene bunod while minimizing side reactions.
Career Highlights
Throughout his career, Hyun Ik Shin has worked with various companies, including Yonsung Fine Chemical Co., Ltd. and Ys Life Science Co. Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Shin has collaborated with notable colleagues such as Kee Young Lee and Chang Young Oh. These partnerships have likely enhanced his research and development efforts in the field of ophthalmic treatments.
Conclusion
Hyun Ik Shin's contributions to glaucoma treatment through his innovative patents demonstrate his dedication to improving patient care. His work continues to influence the field of ophthalmology and showcases the importance of innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile